In the News

Share
1669 News Items found
“Patients really want to feel empowered to do some­thing for their own health,” says Dr. Urvi Shah.
Food as Medicine: Why One Doctor Thinks Diet Could Help Control Cancer
When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should and shouldn’t eat.
Roxanne Joseph
New Leads in an Unsolved Mystery
After treatment for rectal cancer, Roxanne Joseph is back to enjoying an active life with her husband, Rory, and their two children. Recent research by MSK computational biologist Henry Walch is shedding light on why colorectal cancer has been more difficult to treat in many Black people.
Feature
Man examining himself.
7 Myths About Testicular Cancer
Learn how testicular cancer is often misunderstood and why it is highly treatable.
Detail shot of a scientist handling samples
MSK Research Highlights, June 29, 2023
New MSK research discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers; examined how tumor-associated macrophages might be turned against cancer; acquired new insights into joint inflammation in rheumatoid arthritis; developed a systems-level platform called epichaperomics to map changes in interactors among thousands of proteins involved in cancer-related processes; and investigated how artificial intelligence could help diagnose an invasive form of breast cancer.
MSK multiple myeloma specialist Urvy Shah
Diets for MGUS, Smoldering Myeloma, and Multiple Myeloma: Q&A With MSK Cancer and Nutrition Experts
Learn how eating a plant-based diet may prevent MGUS and smoldering myeloma from developing into multiple myeloma, according to MSK research.
MSK thoracic surgeon Prasad Adusumilli
New Design Could Make CAR T Cells a More Effective Immunotherapy for Solid Tumors
Learn how researchers engineered CAR T cells to work better by using a mutation in a gene called c-KIT that drives cancer cell growth.
Susan Everson, a transgender woman, was treated at MSK for stage 3 colorectal cancer. She says her care team made her feel welcome, in addition to offering her the most advanced therapies. Susan is now cancer free.
Being Seen: Compassionate Cancer Treatment for Transgender People
Learn how MSK cares for transgender cancer patients, treating them with respect and medical expertise. Staff are specially trained to understand their needs.
Feature
Gloved hands holding a pipette.
Your Gut Microbiome: How To Improve It, Its Effects on the Immune System, and More
This story answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer.
A breast cancer cell containing micronuclei
MSK-Led Research Finds Unexpected Link Between Chromosomal Instability and Epigenetic Alterations
MSK-led research found an unexpected link between chromosomal instability and epigenetic alternations, both of which are hallmarks of cancer — especially advanced, drug-resistant cancers.
Kieran Healy is seen smiling outdoors next to his bike, after successful treatment for lymphoma at Memorial Sloan Kettering.
How MSK’s Rapid Diagnosis Got Kieran Treated Quickly for Lymphoma
Kieran Healy was feeling worse by the day. A new father at 43 years old, he was bone-tired and losing weight. He had night sweats and a strange lump in his belly. His local hospital in Manhattan ordered an ultrasound and a CT (computed tomography) scan — but they were scheduled over a month away.
Feature
Dr. Alicia Latham, Dr. Michael Walsh, Dr. Zsofia Stadler, and Megha Ranganathan
Inherited Cancer Risks: New Insights from MSK Presented at 2023 ASCO Meeting
MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
MSK neuro-oncologist Ingo Mellinghoff
Experimental Drug for Low-Grade Glioma With IDH Gene Mutation Shows Promise
A new experimental drug could be an effective treatment for some people with low-grade glioma.
See Dr. Deb Schrag standing in a hallway. She led a clinical trial involving rectal cancer at Memorial Sloan Kettering.
Rectal Cancer Treatment Without Radiation: A New Option
Learn about a clinical trial at Memorial Sloan Kettering that gives people with rectal cancer a new option to be treated without radiation. The research shows that a well-known chemotherapy regimen used alone can be just as effective as chemotherapy given with radiation before surgery. The new method may reduce side effects associated with radiation such as loss of fertility and impaired bladder and sexual function.
Dr. James Harding
For Advanced, HER2-Amplified Bile Duct Cancers, Antibody Treatment Trial Shows Promising Results
New research finds an antibody treatment helped shrink tumors in some patients with bile duct cancers — specifically a subset of people whose tumors make a high amount of the HER2 protein, which can cause cells to multiply too quickly.
In the Lab
Dr. Piro Lito
Potential Drug Shows Promise Targeting a Range of KRAS-Driven Cancers in the Lab
MSK investigators report exciting results for a new molecule that can block 16 different mutated forms of the KRAS protein. In the lab, the compound was effective against many cancer cell lines and in mouse models of lung cancer and colorectal cancer.
Feature
Back row from left to right: Zongmin Wang, Miguel Miranda-Román, Stella Paffenholz, Anton Dobrin, Bradley Benjamin, Caroline Gleason, Paige Arnold, and Mollie Chipman. Front row, from left to right: Yasemin Kaygusuz, Maria Sirenko, Buren Li, Tingxu Chen, Nayan Jain, Florisela Herrejon Chavez, and Adele Whaley.
MSK’s 2023 Commencement Celebrates Largest Class in History and Honors Award Winners
MSK's 44th annual Academic Convocation and Commencement celebrated the Gerstner Sloan Kettering Graduate School of Biomedical Sciences class of 2023, honored students graduating from the Sloan Kettering Division of the Weill Cornell Medicine Graduate School of Medical Sciences, and recognized winners of several awards and fellowships.
a composite showing a black and white, historical photo of a woman at the microscope on the left, and a modern version of a similar picture on the right
MSK’s Sloan Kettering Institute Celebrates 75 Years of Discovery
Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology, as well as driven practice-changing innovations in the treatment of cancer.
An MSK scientist pipettes in the lab
MSK Research Highlights, May 18, 2023
New MSK research shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating tumors by delivering a viral-based immunotherapeutic to melanoma and breast cancer in mouse models.
Dr. Grady Nelson interviews a student scientist at the science fair.
MSK Supports STEM Education at Yankee Stadium Science Fair
Three MSK researchers served as guest judges at the event, which celebrated students’ academic achievements.
Feature
Dr. Michael Overholtzer
17 Gerstner Sloan Kettering Students Will Graduate This Year
Seventeen scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 17, 2023, as part of Memorial Sloan Kettering’s 44th annual academic convocation.